Paul J. Maddon

Paul Maddon is a biotechnology entrepreneur who serves as Vice Chairman of the Board of Progenics Pharmaceuticals, Inc., a publicly traded biopharmaceutical company. He founded Progenics in 1986 while an MD-PhD student at Columbia University and served as Chairman, Chief Executive Officer, and Chief Science Officer until retiring in 2012. 
Maddon is a molecular virologist and immunologist. He isolated the gene encoding CD4 and demonstrated that CD4 serves as the primary receptor for entry of ...

Source URL: